Isaac Manke - 30 Jun 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Rogan Nunn, by power of attorney
Issuer symbol
OKUR
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
4
Filing time
02 Jul 2025, 16:26:16 UTC
Previous filing
30 May 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Manke Isaac Director C/O ONKURE THERAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER /s/ Rogan Nunn, by power of attorney 02 Jul 2025 0001622769

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OKUR Class A Common Stock Award $0 +6,311 +182% $0.000000 9,780 30 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.